➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Merck
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Amgen Inc. v. Amneal Pharmaceuticals (D. Del. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Amgen Inc. v. Amneal Pharmaceuticals
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Amgen Inc. v. Amneal Pharmaceuticals
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Amgen Inc. v. Amneal Pharmaceuticals (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-09-22 1 Complaint action for infringement of U.S. Patent No. 9,375,405 (the “‘405 patent”). 7. This action… THE PATENT-IN-SUIT 14. United States Patent No. 9,375,405, entitled “Rapid…United States Patent and Trademark Office (“PTO”) on June 28, 2016. A copy of the ‘405 patent is attached…15. The ‘405 patent is assigned to Amgen and Amgen is the owner of the ‘405 patent. …405 patent when Aurobindo Ltd notified Amgen of its Paragraph IV Certification of the ‘405 patent. External link to document
2016-12-15 14 Status Report undergo parathyroidectomy. U.S. Patent No. 9,375,405 (the “’405 patent”) is listed in Approved Drug Products…‘405 patent invalid. 2. A judgment that no asserted claim of the ‘405 patent is infringed…Substance of the Actions These are Hatch-Waxman patent infringement actions relating to cinacalcet hydrochloride…United States prior to the expiration of the ’405 patent. By letter dated August 5, 2016, Aurobindo notified…United States prior to the expiration of the ’405 patent. By letter dated August 3, 2016, Micro Labs notified External link to document
2017-07-19 186 Memorandum and Order ORDER Construing the Terms of U.S. Patent No. 9,375,405. Signed by Judge Gregory M. Sleet on 7/19…September 2016 1:16-cv-00853-MSG 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Moodys
Boehringer Ingelheim
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.